Association of <i>CYP2C19</i> Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke
Tomotaka Tanaka(Shimane University), Kazuyuki Nagatsuka(United Cerebral Palsy), Masahiro Yasaka(National Kyushu Medical Center), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Shigeki Miyata(Japanese Red Cross Society, Japan), Yasuhiro Manabe(National Hospital Organization), Shinichiro Uchiyama(International University of Health and Welfare), Masafumi Ihara(Kyoto University), Shu Amano(Amherst College), Takeo Abumiya(Hokkaido Orthopedic Surgery Memorial Hospital), BooHan Hyun(Osaka National Hospital), Ryuzo Fukunaga(Hoshigaoka Medical Center), Toshimitsu Hamasaki(National Cerebral and Cardiovascular Center), Yasumasa Yamamoto(Krankenhaus vom Roten Kreuz), Haruko Yamamoto(National Cerebral and Cardiovascular Center), Hiroshi Yamagami(Osaka City University), Yasuhiro Ito(Toyota Memorial Hospital), Kazuo Kitagawa(Tokyo Women's Medical University Hospital), Jyoji Nakagawara(National Cerebral and Cardiovascular Center), Kazuki Fukuma(Kyoto University), Eisuke Furui(Kohnan Hospital), Toshiyuki Miyata(National Cerebral and Cardiovascular Center)
Cited by 29
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|809
White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion
|Stroke|2004|575
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke
|New England Journal of Medicine|2018|363